Brusatol derivative ameliorates rheumatoid arthritis and atherosclerosis with associated suppression of mitochondrial fission
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.158171 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Ruicong Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian, 116044, Liaoning, China; Department of Cardiology, The…. Hauptthemen laut MEDLINE: Atherosclerosis, Arthritis, Rheumatoid, Quassins, Mitochondrial Dynamics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Dalian Science and Technology Innovation Fund, University of Science and Technology Liaoning, Dalian Medical University.
Abstract (Originalsprache)
BACKGROUND: Brusatol (BRU), a major bioactive quassinoid isolated from Brucea javanica, has shown potential in the treatment of inflammatory diseases. As mitochondrial dysfunction has been implicated in chronic inflammatory disorders, modulation of mitochondrial homeostasis may offer a potential approach for the treatment of rheumatoid arthritis (RA) and atherosclerosis (AS). PURPOSE: To develop a novel BRU derivative through rational modification at the C11‑hydroxyl group and to compare the therapeutic effects of BRU and its derivative BRUD in experimental models of RA and AS, with particular focus on mitochondrial regulation and Drp1-associated signaling. STUDY DESIGN: This study combined in vivo and in vitro experiments to evaluate the pharmacological effects of BRU and BRUD and investigate the underlying mechanisms. METHODS: The chemical constituents of BRU and BRUD were confirmed by HPLC and NMR spectroscopy (1H and 13C). Their effects were evaluated in vivo using collagen-induced arthritis (CIA) rats and apolipoprotein E-deficient (ApoE-/-) mice, and in vitro using RA fibroblast-like synoviocytes (RA-FLS), as well as IL-8-stimulated normal endothelial cells (ECs) and smooth muscle cells (SMCs). Cell viability, apoptosis, migration, invasion, adhesion, and tube formation assays were performed to assess cellular responses. Histological, biochemical, flow cytometric, confocal imaging, Western blot, molecular docking/molecular dynamics, surface plasmon resonance (SPR), and Drp1 overexpression rescue assays were performed to assess disease phenotypes, mitochondrial alterations, and Drp1-associated signaling. RESULTS: In vivo studies demonstrated that both compounds ameliorated joint damage in CIA rats and reduced atherosclerotic lesion burden in ApoE-/- mice. In vitro, BRUD more effectively inhibited pathogenic FLS activation than BRU, and restored normal EC and SMC function. Mechanistically, the stronger activity of BRUD was associated with attenuation of Drp1-related mitochondrial fission, accompanied by reduced mtROS levels and restoration of ΔΨm. CONCLUSIONS: These findings suggest that BRUD exhibits improved activity compared with BRU in RA and AS models, with protective effects associated with modulation of mitochondrial dysfunction, supporting its further evaluation as a lead compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian, 116044, Liaoning, China; Department of Cardiology, The Second Hospital of Dalian Medical University, Dalian, 116021, Liaonin…
- Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian, 116044, Liaoning, China.
- School of Biological Science and Technology, University of Jinan, Jinan 250022, China. Electronic address: bio_zhangjs@ujn.edu.cn.
- Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian, 116044, Liaoning, China. Electronic address: yinchunlai1990@163.com.
- Department of Immunology, College of Basic Medical Science, Dalian Medical University, Dalian, 116044, Liaoning, China. Electronic address: lixia416@163.com.
Förderung
- Dalian Science and Technology Innovation Fund
- University of Science and Technology Liaoning
- Dalian Medical University
- Department of Education of Liaoning Province
- National Natural Science Foundation of China
Zitieren
APA
Ma, R., Liu, J., Yang, S., Chen, G., Ren, J., Zhang, C., Chen, X., Zhao, Y., Zhang, J., Yin, C., & Li, X. (2026). Brusatol derivative ameliorates rheumatoid arthritis and atherosclerosis with associated suppression of mitochondrial fission. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158171
Vancouver
Ma R, Liu J, Yang S, Chen G, Ren J, Zhang C, et al. Brusatol derivative ameliorates rheumatoid arthritis and atherosclerosis with associated suppression of mitochondrial fission. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158171
BibTeX
@article{Ma2026,
author = {Ma, Ruicong and Liu, Jiaqing and Yang, Siwen and Chen, Guanghong and Ren, Jinyi and Zhang, Cheng and Chen, Xianmei and Zhao, Ying and Zhang, Junsheng and Yin, Chunlai and Li, Xia},
title = {Brusatol derivative ameliorates rheumatoid arthritis and atherosclerosis with associated suppression of mitochondrial fission},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.158171}
}
EUVIMED